Dexmedetomidine protects against lung ischemia-reperfusion injury by the PI3K/Akt/HIF-1α signaling pathway.
about
Lung ischemia reperfusion injury: the therapeutic role of dipeptidyl peptidase 4 inhibition.Paravertebral dexmedetomidine as an adjuvant to ropivacaine protects against independent lung injury during one-lung ventilation: a preliminary randomized clinical trial.Inhibition of GLUT-1 expression and the PI3K/Akt pathway to enhance the chemosensitivity of laryngeal carcinoma cells in vitro
P2860
Dexmedetomidine protects against lung ischemia-reperfusion injury by the PI3K/Akt/HIF-1α signaling pathway.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Dexmedetomidine protects again ...... /Akt/HIF-1α signaling pathway.
@en
Dexmedetomidine protects again ...... /Akt/HIF-1α signaling pathway.
@nl
type
label
Dexmedetomidine protects again ...... /Akt/HIF-1α signaling pathway.
@en
Dexmedetomidine protects again ...... /Akt/HIF-1α signaling pathway.
@nl
prefLabel
Dexmedetomidine protects again ...... /Akt/HIF-1α signaling pathway.
@en
Dexmedetomidine protects again ...... /Akt/HIF-1α signaling pathway.
@nl
P2093
P2860
P1476
Dexmedetomidine protects again ...... /Akt/HIF-1α signaling pathway.
@en
P2093
Fan-Min Meng
Fu-Shan Xue
Jia-Qiang Zhang
P2860
P304
P356
10.1007/S00540-016-2214-1
P577
2016-07-13T00:00:00Z